marketcaparena
Search

    ENSC

    Ensysce Biosciences, Inc.

    Company overview

    Market capitalization
    $7.80M
    Employees
    8
    Latest publication
    2026-09-29
    About Ensysce Biosciences, Inc.

    Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat opioid use disorder. Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue1,164,315USD960,999USD—493,104USD1,371,438USD1,319,772USD—3,418,853USD
    Research Development2,471,752USD3,346,881USD3,613,029USD2,954,909USD1,923,430USD1,885,528USD3,802,630,000,000USD1,690,674USD
    Selling General Administrative1,268,952USD1,176,348USD—1,279,290USD1,198,523USD1,401,756USD—1,083,433USD
    General And Administrative Expenses1,268,952USD1,176,348USD—1,279,290USD1,198,523USD1,401,756USD—1,083,433USD
    Total Operating Expenses3,740,704USD4,523,229USD4,664,161USD4,234,199USD3,121,953USD3,287,284USD4,880,135,000,000USD2,774,107USD
    Operating Income-2,576,389USD-3,562,230USD—-3,741,095USD-1,750,515USD-1,967,512USD—644,746USD
    Total Other Income Expense Net5,514USD5,815USD—11,967USD16,998USD21,939USD—17,023USD
    Interest Expense320USD3,923USD—6,369USD3,160USD3,856USD—4,063USD
    Net Income-2,570,875USD-3,556,415USD-2,767,969USD-3,729,128USD-1,733,517USD-1,945,573USD-3,564,422,000,000USD661,769USD
    Minority Interest-166USD———-166USD———
    Net Income Applicable To Common Shares-2,570,709USD-3,556,415USD—-3,729,128USD-1,733,351USD-1,945,573USD—661,769USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue5,066,650USD5,210,031USD2,230,520USD2,523,383USD3,531,199USD3,931,209USD1,763,961USD0USD
    Research Development10,376,895USD7,219,437USD7,587,473USD19,835,875USD4,690,082USD4,389,579USD3,402,301USD—
    Selling General Administrative4,930,701USD4,720,728USD5,361,234USD6,909,603USD18,711,548USD1,155,000USD6,929,904USD—
    General And Administrative Expenses4,930,701USD4,720,728USD5,361,234USD6,909,603USD————
    Total Operating Expenses15,307,596USD11,940,165USD12,948,707USD26,745,478USD23,401,630USD5,544,295USD3,328,674USD-600,005USD
    Operating Income-10,240,946USD-6,730,134USD-10,718,187USD-24,222,095USD-19,870,431USD-1,613,287USD-3,328,674USD-959,240USD
    Total Other Income Expense Net64,759USD-1,256,875USD91,912USD14,410USD-9,275,470USD1,452,412USD4,249,828USD3,635,189USD
    Interest Expense18,767USD1,290,444USD353,945USD109,525USD1,295,307USD995,496USD0USD0USD
    Net Income-10,176,187USD-7,987,009USD-10,626,275USD-24,207,685USD-29,145,901USD56,770USD1,476,354USD2,122,033USD
    Minority Interest-487USD-74USD-13,201USD-35,393USD-62,190USD-217,625USD-217,625USD—
    Net Income Applicable To Common Shares-10,175,700USD-7,987,225USD-10,626,011USD-25,085,496USD-29,886,851USD4,310,769USD365,954USD2,122,033USD
    Cost Of Revenue—————201USD3,328,674USD1,559,245USD
    Gross Profit—————3,931,008USD-3,328,674USD-1,559,245USD
    Interest Income—————939,650USD4,249,830USD3,635,190USD
    Net Interest Income—————-995,496USD——
    Income Before Tax—————-160,875USD921,154USD2,675,949USD
    Income Tax Expense—————777,851USD-555,200USD-553,916USD
    Tax Provision—————244,490USD555,200USD553,920USD
    Net Income From Continuing Ops—————4,310,769USD365,954USD2,122,033USD
    Ebit—————834,620USD-3,328,674USD-959,240USD
    Ebitda—————834,821USD-3,328,674USD-959,240USD
    Depreciation And Amortization—————201USD201USD161,141USD
    Reconciled Depreciation—————201USD——
    Non Operating Income Net Other—————5,924,103USD4,249,828USD3,635,189USD
    Unclassified Operating Expenses——————-7,003,531USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,957,273USD2,167,803USD7,452,479USD3,179,464USD5,574,455USD4,611,874USD5,597,232USD9,384,724USD
    Cash And Equivalents676,704USD745,482USD4,310,354USD1,673,218USD2,211,575USD3,052,491USD3,502,077USD4,153,592USD
    Total Current Assets2,846,210USD2,008,540USD7,242,468USD2,928,270USD5,281,595USD4,400,991USD5,344,682USD9,090,507USD
    Other Current Assets20,550USD25,545USD18,000USD68,134USD241,030USD222,698USD18,000USD18,000USD
    Total Liabilities4,068,106USD2,836,815USD4,567,729USD2,304,750USD2,514,043USD1,891,356USD2,217,293USD2,804,997USD
    Total Current Liabilities4,068,106USD2,836,815USD4,567,729USD2,304,715USD2,513,010USD1,761,176USD2,207,197USD2,801,784USD
    Total Stockholder Equity-781,697USD-340,042USD3,213,720USD1,203,363USD3,389,061USD3,049,001USD3,708,422USD6,908,210USD
    Total Equity Including Noncontrolling Interest-1,110,833USD-669,012USD2,884,750USD874,714USD3,060,412USD2,720,518USD3,379,939USD6,579,727USD
    Property Plant Equipment Net111,063USD117,596USD124,129USD123,643USD————
    Accounts Payable1,977,629USD1,610,186USD3,267,610USD463,458USD1,042,832USD615,295USD1,357,079USD1,967,573USD
    Common Stock1,624USD929USD459USD320USD241USD165USD136USD1,387USD
    Retained Earnings-145,847,123USD-143,276,414USD-139,719,999USD-136,952,351USD-133,223,223USD-131,489,872USD-129,544,299USD-125,979,877USD
    Other Non Current Assets—41,667USD85,882USD127,551USD292,860USD210,883USD252,550USD294,217USD
    Other Non Current Liabilities———35USD1,033USD130,180USD10,096USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets7,452,479USD5,597,232USD2,708,085USD5,885,052USD16,417,349USD12,854,634USD196,511,899USD204,831,755USD
    Cash And Equivalents4,310,354USD3,502,077USD1,123,604USD3,147,702USD12,264,736USD———
    Total Current Assets7,242,468USD5,344,682USD2,288,868USD5,299,169USD15,662,593USD226,464USD1,199,722USD1,916,016USD
    Other Current Assets18,000USD18,000USD18,000USD—————
    Other Non Current Assets85,882USD252,550USD419,217USD585,883USD754,756USD———
    Total Liabilities4,567,729USD2,217,293USD3,359,352USD9,914,704USD24,575,407USD14,061,692USD10,337,313USD7,439,650USD
    Total Current Liabilities4,567,729USD2,207,197USD3,332,964USD9,464,210USD16,481,666USD260,404USD2,771,045USD437,886USD
    Total Stockholder Equity3,213,720USD3,708,422USD-322,858USD-3,714,444USD-7,878,243USD-1,207,058USD5,000,001USD5,000,001USD
    Total Equity Including Noncontrolling Interest2,884,750USD3,379,939USD-651,267USD-4,029,652USD-8,158,058USD-1,207,058USD186,174,586USD197,392,105USD
    Property Plant Equipment Net124,129USD———————
    Accounts Payable3,267,610USD1,357,079USD1,936,007USD2,943,791USD301,104USD260,404USD2,771,045USD429,246USD
    Common Stock459USD136USD315USD642USD2,464USD622USD638USD604USD
    Retained Earnings-139,719,999USD-129,544,299USD-121,557,074USD-110,931,063USD-85,845,567USD-1,207,680USD2,456,794USD2,090,840USD
    Other Non Current Liabilities—10,096USD26,388USD310,346USD3,652,790USD———
    Short Term Debt———27,315USD24,874USD———
    Other Current Liabilities———————8,640USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentDisclosureDeterministicFinalDisclosureDeterministicAmendment

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USDQ3 20222022-09-30 · USD
    Depreciation13,066USD0USD0USD0USD0USD———
    Stock Based Compensation10,613USD152,747USD106,889USD80,574USD59,756USD250,224USD194,550USD855,160USD
    Change To Liabilities-1,355,046USD-893,621USD-314,247USD-57,666USD-1,795,404USD-2,027,375USD-1,669,162USD984,410USD
    Change In Working Capital-1,355,046USD-893,621USD-314,247USD-57,666USD-1,795,404USD-2,027,375USD-1,669,162USD984,410USD
    Operating Cash Flow-5,463,383USD-6,280,459USD-4,414,280USD-6,738,610USD-5,718,294USD-8,978,107USD-6,715,461USD-14,591,819USD
    Financing Cash Flow1,829,733USD4,575,243USD3,123,778USD9,768,598USD5,637,921USD7,294,786USD7,397,241USD6,825,664USD
    Change In Cash-3,633,650USD-1,828,859USD-1,290,502USD3,029,988USD-80,373USD-1,683,321USD681,780USD-7,761,655USD
    End Cash Flow676,704USD1,673,218USD2,211,575USD4,153,592USD1,043,231USD1,464,381USD3,829,482USD4,503,081USD
    Capital Expenditures—-123,643USD——————
    Investing Cash Flow—-123,643USD—————4,500USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation6,533USD6,530USD——0USD——25,735USD
    Stock Based Compensation8,743USD249,107USD96,576USD—16,251USD——26,549USD
    Change To Liabilities-1,663,513USD———-741,784USD———
    Change In Working Capital-1,663,513USD793,223USD2,343,585USD—-741,784USD——-388,394USD
    Operating Cash Flow-3,500,925USD———-1,707,412USD———
    Financing Cash Flow-63,947USD——3,123,778,000,000USD1,257,826USD9,881,173,000,000USD9,768,598,000,000USD—
    Change In Cash-3,564,872USD2,637,136USD-538,357USD-1,290,502,000,000USD-449,586USD2,378,473,000,000USD3,029,988,000,000USD-2,361,118USD
    End Cash Flow745,482USD——2,211,575,000,000USD3,052,491USD3,502,077,000,000USD4,153,592,000,000USD—
    Net Income—-5,624,663USD-3,729,128USD-1,733,517,000,000USD—-3,564,422,000,000USD661,769,000,000USD-1,967,793USD
    Other Non Cash Items—3,056,500USD-577,212USD————-5,988USD
    Change To Account Receivables—-415,934USD1,200,568USD————-128,000USD
    Total Cash From Operating Activities—-1,525,833USD-1,866,179USD————-2,309,891USD
    Capital Expenditures—-123,640USD-123,643USD————0USD
    Free Cash Flow—-1,525,833USD-1,989,822USD————-2,309,891USD
    Total Cashflows From Investing Activities—-123,640USD-123,643USD—————
    Net Borrowings—0USD0USD—————
    Total Cash From Financing Activities—4,162,969USD1,451,465USD————-51,227USD
    Sale Purchase Of Stock—9,847,090USD5,187,730USD—————
    Issuance Of Capital Stock—3,975,000USD0USD————0USD
    Begin Period Cash Flow—1,673,218USD2,211,575USD————3,404,349USD
    End Period Cash Flow—4,310,354USD1,673,218USD————1,043,231USD
    Other Cashflows From Financing Activities—-496,389USD1,491,444USD————-51,227USD
    Unclassified Financing Cash Flow—-5,187,732USD-5,227,709USD—————
    Other Cashflows From Investing Activities——-123,643USD—————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyDisclosurePreliminaryDisclosureDeterministicFinalDisclosurePreliminaryDisclosurePreliminaryLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Depreciation6,533USD0USD0USD—151USD———
    Stock Based Compensation177,086USD110,723USD879,160USD1,071,843USD121,764USD———
    Change To Liabilities1,815,658USD-578,928USD-1,234,287USD2,642,686USD-1,423,494USD787,586USD2,341,799USD317,282USD
    Change In Working Capital1,815,658USD-578,928USD-1,234,287USD2,642,686USD-1,423,494USD787,586USD2,341,799USD317,282USD
    Operating Cash Flow-7,806,292USD-7,502,700USD-10,779,982USD-17,887,439USD-8,242,177USD-864,439USD-1,424,792USD-1,238,263USD
    Capital Expenditures-123,643USD———————
    Investing Cash Flow-123,643USD——4,500USD—183,403,653USD11,853,390USD838,587USD
    Financing Cash Flow8,738,212USD9,881,173USD8,755,884USD8,765,905USD20,312,699USD-183,551,163USD-11,025,845USD-32,000USD
    Change In Cash808,277USD2,378,473USD-2,024,098USD-9,117,034USD12,070,522USD-1,011,949USD——
    End Cash Flow4,310,354USD3,502,077USD1,123,604USD3,147,702USD12,264,736USD49,202USD——
    Other Non Cash Items———60,035USD————
    Net Investments—————-1,698,862USD-566,288USD—
    Unclassified Investing Cash Flow—————185,102,515USD12,419,678USD—
    Net Common Stock Issuance—————-184,776,163USD-11,583,473USD—
    Unclassified Financing Cash Flow—————1,225,000USD557,628USD—
    Deferred Income Tax——————-1,764USD1,764USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentDisclosureDeterministicFinalDisclosureDeterministicAmendment

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2024Yearly · 2024-12-31ProductMPAR3,086,464USDDisclosure
    FY 2024Yearly · 2024-12-31ProductTAAPOUD2,123,567USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductMPAR1,782,805USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductTAAPOUD1,636,048USDDisclosure
    FY 2023Yearly · 2023-12-31ProductMPAR1,293,238USDDisclosure
    FY 2023Yearly · 2023-12-31ProductTAAPOUD937,282USDDisclosure
    Q4 2023Quarterly · 2023-12-31ProductMPAR254,754USDDisclosure
    Q4 2023Quarterly · 2023-12-31ProductTAAPOUD260,279USDDisclosure
    Q3 2023Quarterly · 2023-09-30ProductMPAR119,942USDDisclosure
    Q3 2023Quarterly · 2023-09-30ProductTAAPOUD315,438USDDisclosure
    Q2 2023Quarterly · 2023-06-30ProductMPAR437,263USDDisclosure
    Q2 2023Quarterly · 2023-06-30ProductTAAPOUD53,209USDDisclosure
    Q1 2023Quarterly · 2023-03-31ProductMPAR481,279USDDisclosure
    Q1 2023Quarterly · 2023-03-31ProductTAAPOUD308,356USDDisclosure
    FY 2022Yearly · 2022-12-31ProductMPAR2,006,885USDDisclosure
    FY 2022Yearly · 2022-12-31ProductTAAPOUD516,498USDDisclosure
    Q3 2022Quarterly · 2022-09-30ProductMPAR206,290USDDisclosure
    Q3 2022Quarterly · 2022-09-30ProductOUD73,061USDDisclosure
    Q1 2022Quarterly · 2022-03-31ProductMPAR504,470USDDisclosure
    Q1 2022Quarterly · 2022-03-31ProductOUD98,628USDDisclosure
    FY 2021Yearly · 2021-12-31ProductMPAR2,646,579USDDisclosure
    FY 2021Yearly · 2021-12-31ProductTAAPOUD884,620USDDisclosure

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.